Nicoară S
Clinica Oftalmologică, Cluj Napoca.
Oftalmologia. 2000;51(2):4-6.
The current therapy of glaucoma (drugs, LASER, surgery) acts mainly on the trabecular meshwork and on the ciliary body. The loss of the visual function in glaucoma is however determined by the disfunction and death of the ganglion cells. The main theories trying to explain the death of the ganglion cells in glaucoma are analyzed. Their practical value is represented by the finding of the ideal neuroprotective drug.
目前青光眼的治疗方法（药物、激光、手术）主要作用于小梁网和睫状体。然而，青光眼患者视觉功能的丧失是由神经节细胞的功能障碍和死亡所决定的。本文分析了试图解释青光眼神经节细胞死亡的主要理论。找到理想的神经保护药物体现了这些理论的实际价值。
